Shanghai Junshi Biosciences Co., Ltd. (SHJBF)
USD 1.97
(51.54%)
USD 1.97
(51.54%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.78 Billion CNY | 44.53% |
| 2022 | 1.23 Billion CNY | 97.0% |
| 2021 | 628.19 Million CNY | -26.16% |
| 2020 | 850.77 Million CNY | -1.41% |
| 2019 | 862.96 Million CNY | 51.29% |
| 2018 | 570.39 Million CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 391.72 Million USD | 6.87% |
| 2024 Q2 | 2.56 Billion CNY | -15.33% |
| 2024 Q1 | 419.72 Million USD | 70.12% |
| 2023 Q4 | 251.8 Million USD | 21.5% |
| 2023 FY | 1.78 Billion CNY | 44.53% |
| 2023 Q1 | 202.49 Million USD | -83.64% |
| 2023 Q2 | 1.4 Billion CNY | 594.76% |
| 2023 Q3 | 207.25 Million USD | -85.27% |
| 2022 Q1 | 630.36 Million USD | 0.35% |
| 2022 Q3 | 203.43 Million USD | -81.64% |
| 2022 Q4 | 1.23 Billion CNY | 508.33% |
| 2022 FY | 1.23 Billion CNY | 97.0% |
| 2022 Q2 | 1.1 Billion CNY | 75.8% |
| 2021 Q2 | 851.56 Million CNY | -2.84% |
| 2021 FY | 628.19 Million CNY | -26.16% |
| 2021 Q4 | 628.19 Million CNY | 1.24% |
| 2021 Q3 | 620.47 Million USD | -27.14% |
| 2021 Q1 | 876.46 Million USD | 3.02% |
| 2020 Q4 | 850.77 Million CNY | -2.89% |
| 2020 FY | 850.77 Million CNY | -1.41% |
| 2020 Q3 | 876.09 Million CNY | -22.87% |
| 2020 Q2 | 1.13 Billion CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 862.96 Million CNY | 0.0% |
| 2019 Q1 | 730.76 Million CNY | 28.12% |
| 2019 FY | 862.96 Million CNY | 51.29% |
| 2019 Q2 | 820.97 Million CNY | 12.35% |
| 2018 Q2 | 229.68 Million CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 570.39 Million CNY | 0.0% |
| 2018 Q4 | 570.39 Million CNY | 143.59% |
| 2018 Q3 | 234.16 Million CNY | 1.95% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bioxytran, Inc. | 1.92 Million USD | -92812.571% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -4240.866% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -444984.348% |
| SQZ Biotechnologies Company | 27.47 Million USD | -6410.746% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -76796.028% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -4023.688% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -5908.528% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -188513.487% |
| Marizyme, Inc. | 18.71 Million USD | -9455.59% |
| Genus plc | 233.1 Million USD | -667.296% |
| Pharming Group N.V. | 171.54 Million USD | -942.623% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -201300.687% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -133019.105% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -238375.6% |
| ContraFect Corporation | 2.88 Million USD | -61981.465% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -123563.383% |
| IMV Inc. | 28.88 Million USD | -6092.263% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -31509.322% |
| ONE Bio Corp. | 19.71 Million USD | -8972.103% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -3011.146% |
| Mesoblast Limited | 118.7 Million USD | -1406.791% |
| MultiCell Technologies, Inc. | 202.58 USD | -882894065.268% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -5303.362% |
| Genscript Biotech Corporation | 417.73 Million USD | -328.155% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -283764.829% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -145505.974% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -43291.21% |
| Biomind Labs Inc. | 735.54 Thousand USD | -243063.137% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -59002.912% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -13661.389% |
| Skye Bioscience, Inc. | 4.61 Million USD | -38653.281% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -497124.709% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -60935.16% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1263744.175% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -1320002.298% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -30363.968% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -6954163.385% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -119556.518% |
| Q BioMed Inc. | 4.1 Million USD | -43417.646% |
| GB Sciences, Inc. | 1.75 Million USD | -101563.155% |
| Alpha Cognition Inc. | 1.22 Million USD | -146459.164% |
| CSL Limited | 12.18 Billion USD | 85.319% |
| Agentix Corp. | 50 Thousand USD | -3577034.0% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -2544.133% |
| Enzolytics Inc. | 996.33 Thousand USD | -179414.081% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Resverlogix Corp. | 6.49 Million USD | -27454.568% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -699674.25% |
| MetaStat, Inc. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -79096.867% |
| argenx SE | 20 Million USD | -8842.835% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -3825.74% |
| HST Global, Inc. | 98.31 Thousand USD | -1819046.859% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -719008.636% |
| Halberd Corporation | 150 Thousand USD | -1192278.0% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -25187.927% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -17491997.8% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -65930.384% |
| GeneThera, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -74494.365% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -779942.392% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1203074.486% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -891437.564% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 2.19 Million USD | -81202.935% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -8698.539% |
| Kadimastem Ltd | 891.22 Thousand USD | -200586.133% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 4.71 Million USD | -37862.401% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -714806.348% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | 33.6 Thousand USD | -5322065.685% |
| Cell Source, Inc. | 9.25 Million USD | -19227.138% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -236419.114% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -236419.114% |
| Affymax, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -369221.927% |
| Itoco Inc. | 228.37 Thousand USD | -783064.242% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -847662.531% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -35793.377% |
| International Stem Cell Corporation | 4.17 Million USD | -42709.167% |
| CytoDyn Inc. | 30.07 Million USD | -5846.825% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -508236.578% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -22771.818% |
| SYBLEU INC | 477.5 Thousand USD | -374469.005% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1459954.694% |
| Rebus Holdings, Inc. | 310 Thousand USD | -576857.097% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -37671.077% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -2865596.249% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -81910.5% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -21407.54% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -20733.628% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -114884.966% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -667275.746% |
| Neutra Corp. | 54.15 Thousand USD | -3302520.208% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -97635.902% |
| PureTech Health plc | 25.51 Million USD | -6910.689% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -145997.779% |
| IXICO plc | 472.02 Thousand USD | -378815.222% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -11438.398% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -2772.6% |
| CSL Limited | 12.18 Billion USD | 85.319% |
| Cellectis S.A. | 92.77 Million USD | -1827.823% |